Sunesis to Present at Upcoming Investor Conferences
August 31 2016 - 6:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
the Company will present at two upcoming investor
conferences:
- 2016 Wells Fargo Healthcare ConferenceWednesday, September 7th
at 2:20 PM Eastern TimeThe Westin Boston Waterfront, Boston
- Rodman & Renshaw 18th Annual Global Investment
ConferenceTuesday, September 13th at 2:10 PM Eastern TimeLotte New
York Palace Hotel, New York
Live webcasts of the presentations will be
available on the Sunesis website at http://ir.sunesis.com. Replays
of the webcasts will be archived on the "Calendar of Events" page
in the Investors and Media section of the Sunesis website for two
weeks.
About Sunesis
PharmaceuticalsSunesis is a biopharmaceutical company
focused on the development and commercialization of new oncology
therapeutics for the potential treatment of solid and hematologic
cancers. Sunesis has built a highly experienced cancer drug
development organization committed to improving the lives of people
with cancer. Currently, the company is focused on pursuing
regulatory approval in Europe for its lead product candidate,
vosaroxin, for the treatment of relapsed or refractory acute
myeloid leukemia in patients aged 60 and older, as well as
advancing its novel kinase-inhibitor pipeline, which includes its
proprietary non-covalent BTK-inhibitor, SNS-062.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles